Business Description
C4 Therapeutics is a clinical-stage drug discovery company focused on developing medicines that eliminate proteins responsible for causing disease. Its most advanced drug, Cemsidomide, is a tablet designed to treat multiple myeloma and has already completed early-stage human trials, while a second cancer drug targets a specific mutation seen in lung cancer patients. The company is also working on treatments for inflammatory and neurological conditions. Founded in 2015 and based in Watertown, Massachusetts, C4 Therapeutics works alongside major pharmaceutical partners including Roche, Merck KGaA, and Betta Pharmaceuticals to advance its pipeline.
